Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to compare the safety and effectiveness of switching treatment
from lamivudine to telbivudine (LdT) against continued lamivudine treatment. Results from
patients who were taking lamivudine and then switched to telbivudine will be compared with
the results from patients who continued on lamivudine alone.